[Ginkgo biloba extract in the treatment of arteriopathy of the lower extremities. A 65-week trial].
Thirty-six patients with arteritis were treated with Ginkgo biloba extract for sixty-five weeks. For the first six months of the treatment period, these patients participated in a double-blind randomised comparison with 35 well matched patients taking placebo. Subsequently, those patients taking Ginkgo biloba extract were given the option to continue treatment on an open basis with follow-up at regular three-monthly intervals. Ginkgo biloba extract therapy gave significantly greater pain relief and walking tolerance than the placebo after 6 months of treatment, and this improvement continued throughout the whole duration of the study. This symptomatic and measurable improvement was combined with excellent tolerance of the drug.
D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008875:Middle Aged; D010919:Placebos; D010936:Plant Extracts / Q000627:therapeutic use; D010946:Plants, Medicinal; D011897:Random Allocation; D013997:Time Factors; D014197:Trees
D010919:Placebos; D010936:Plant Extracts
L'extrait de Ginkgo biloba dans le traitement de l'artériopathie des membres inférieurs. Etude sur 65 semaines.